Diffuse Large B-Cell Lymphoma (DLBCL) Latest Advances

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs.

Journal: Cell transplantation

Published: December 16, 2025

Prebiopsy Steroids and Diagnostic Yield in Patients With Diffuse Large B-Cell Lymphoma.

Journal: JAMA network open

Published: December 11, 2025

Bridging the Gap: Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: Long-Term Benefit, Yet Real-World Complexity.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 10, 2025

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma.

Journal: Future oncology (London, England)

Published: December 10, 2025

Different initial responses following epcoritamab therapy for relapsed diffuse large B-cell lymphoma with multiple subcutaneous tumors

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 07, 2025

T-cell lymphoma arising during epcoritamab therapy for relapsed diffuse large B-cell lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 07, 2025

Between Blood and Tumor: Retroperitoneal Hematoma Look-Alike Revealed as Diffuse Large B-Cell Lymphoma.

Journal: Cureus

Published: December 06, 2025

Could treatment modification based on early response assessment improve results in DLBCL?

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

BK Virus Nephropathy Associated With Prolonged Immune Effector Cell-Associated Hematotoxicity Following Anti-CD19 CAR-T-Cell Therapy for Diffuse Large B-Cell Lymphoma in a Nontransplant Patient: A Case Report.

Journal: Kidney medicine

Published: December 04, 2025

Sweet stuff is dangerous in DLBCL.

Journal: Blood

Published: December 04, 2025

Spindle-cell variant of diffuse large B-cell lymphoma in the uterine cervix: a case report and literature review.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: November 30, 2025

Filters

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs.

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs.

Prebiopsy Steroids and Diagnostic Yield in Patients With Diffuse Large B-Cell Lymphoma.

Prebiopsy Steroids and Diagnostic Yield in Patients With Diffuse Large B-Cell Lymphoma.

Bridging the Gap: Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: Long-Term Benefit, Yet Real-World Complexity.

Bridging the Gap: Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: Long-Term Benefit, Yet Real-World Complexity.

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma.

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma.

Different initial responses following epcoritamab therapy for relapsed diffuse large B-cell lymphoma with multiple subcutaneous tumors

Different initial responses following epcoritamab therapy for relapsed diffuse large B-cell lymphoma with multiple subcutaneous tumors

T-cell lymphoma arising during epcoritamab therapy for relapsed diffuse large B-cell lymphoma

T-cell lymphoma arising during epcoritamab therapy for relapsed diffuse large B-cell lymphoma

Between Blood and Tumor: Retroperitoneal Hematoma Look-Alike Revealed as Diffuse Large B-Cell Lymphoma.

Between Blood and Tumor: Retroperitoneal Hematoma Look-Alike Revealed as Diffuse Large B-Cell Lymphoma.

Could treatment modification based on early response assessment improve results in DLBCL?

Could treatment modification based on early response assessment improve results in DLBCL?

Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?

Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?

BK Virus Nephropathy Associated With Prolonged Immune Effector Cell-Associated Hematotoxicity Following Anti-CD19 CAR-T-Cell Therapy for Diffuse Large B-Cell Lymphoma in a Nontransplant Patient: A Case Report.

BK Virus Nephropathy Associated With Prolonged Immune Effector Cell-Associated Hematotoxicity Following Anti-CD19 CAR-T-Cell Therapy for Diffuse Large B-Cell Lymphoma in a Nontransplant Patient: A Case Report.

Sweet stuff is dangerous in DLBCL.

Sweet stuff is dangerous in DLBCL.

Spindle-cell variant of diffuse large B-cell lymphoma in the uterine cervix: a case report and literature review.

Spindle-cell variant of diffuse large B-cell lymphoma in the uterine cervix: a case report and literature review.